Solventum Corp | SOLV - Fremdkapital





Fremdkapital Veränderung Datum
Abbott USD 29.64B 19.74B 2026-03
Align Technology USD 0 0 2024-12
Baxter International USD 8.62B 6M 2026-06
Becton, Dickinson and Co. USD 14.71B 2.21B 2026-03
Cencora USD 12.18B 4.6B 2026-03
Dexcom USD 1.3B 200K 2026-06
Insulet USD 929.5M 0 2026-06
Solventum Corp USD 4.57B 2M 2026-06
West Pharmaceutical Services USD 202.9M 100K 2026-06
Zimmer Biomet Holdings USD 6.28B 17.6M 2026-06